Research demonstrates that injection drug users with HIV and/or AIDS have difficulty adhering to complex regimens of HIV medications. Because of the risk of increased viral resistance associated with irregular medication adherence, there is considerable clinical need to assist clients who abuse substances in taking their antiretroviral medications on time and as directed. This article outlines intervention strategies to improve medication adherence among clients who are in methadone maintenance. In this treatment manual, the authors delineate contingency management procedures, including voucher incentives and a fishbowl lottery prize system. They also describe intervention elements and adherence tools for medication coaching. The purpose of this manual is to describe the intervention procedures for clinicians and to serve as a resource for drug abuse treatment programs that serve clients who are HIV-positive.
Amass, L., & Kamien, J. (2004). A tale of two cities: Financing two voucher programs for substance abusers through community donations. Experimental and Clinical Psychopharmacology, 12, 147-155.
2.
Babiker, I. E., Cooke, P. R., & Gillett, M. G. (1989). How useful is riboflavin as a tracer of medication compliance?Journal of Behavioral Medicine, 12, 25-38.
3.
Bangsberg, D., Bronstone, A., & Hoffman, R. (2002). A computer-based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy. AIDS Care, 14, 3-15.
4.
Biollaz, J. (1999). Power View (Version 1.2.2) [Computer software]. Zug, Switzerland: AARDEX Ltd.
5.
Boffito, M., Rossati, A., Reynolds, H. E., Hoggard, P. G., Back, D. J., & Di Perri, G. (2002). Undefined duration of opiate withdrawal induced by efavirenz in drug users with HIV infection and undergoing chronic methadone treatment. AIDS Research and Human Retroviruses, 18, 341-342.
6.
Bova, C. A., Fennie, K. P., Knafl, G. J., Dieckhaus, K. D., Watrous, E., & Williams, A. B. (2005). Use of electronic monitoring devices to measure antiretroviral adherence: Practical considerations. AIDS and Behavior, 9, 103-110.
7.
Carroll, K. M., Ball, S. A., Nich, C., O’Connor, P. G., Eagan, D. A., Frankforter, T. L., et al. (2001). Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence. Archives of General Psychiatry, 58, 755-761.
8.
Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
9.
Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care and STDs, 17, 169-177.
10.
Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12, 255-266.
11.
Des Jarlais, D. C., Paone, D., Milliken, J., Turner, C. F., Miller, H., Gribble, J., et al. (1999). Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial. Lancet, 353, 1657-1661.
12.
Donatelle, R. J., Prows, S. L., Champeau, D., & Hudson, D. (2000). Randomised controlled trial using social support and financial incentives for high risk pregnant smokers: Significant other supporter (SOS) program. Tobacco Control, 9, iii67-iii69.
13.
Elk, R., Grabowski, J., Rhoades, H., Spiga, R., Schmitz, J., & Jennings, W. (1993). Compliance with tuberculosis treatment in methadone-maintained patients: Behavioral interventions. Journal of Substance Abuse Treatment, 10, 371-382.
14.
Elk, R., Schmitz, J., Spiga, R., Rhoades, H., Andres, R., & Grabowski, J. (1995). Behavioral treatment of cocaine-dependent pregnant women and TB-exposed patients. Addictive Behaviors, 20, 533-542.
15.
Higgins, S. T., & Silverman, K. (1999). Motivating behavior change among illicit-drug abusers. Washington, DC: American Psychological Association.
16.
Hugen, P. W. H., Langebeek, N., Burger, D. M., Zomer, B., Van Leusen, R., Schuurman, R., et al. (2002). Assessment of adherence to HIV protease inhibitors: Comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. Journal of Acquired Immune Deficiency Syndromes, 30, 324-334.
17.
Kelly, J. A., & Kalichman, S. C. (2002). Behavioral research in HIV/AIDS primary and secondary prevention: Recent advances and future directions. Journal of Consulting and Clinical Psychology, 70, 626-639.
18.
Maher, K., Klimas, N., Fletcher, M. A., Cohen, V., Maggio, C. M., Triplett, J., et al. (1999). Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an urban Veterans Affairs Medical Center. Journal of Acquired Immune Deficiency Syndromes, 22, 358-363.
19.
Marzolini, C., Troillet, N., Telenti, A., Baumann, P., Decosterd, L. A., & Eap, C. B. (2000). Efavirenz decreases methadone blood concentrations. AIDS, 14, 1291-1291.
20.
Mathews, W. C., Mar-Tang, M., Ballard, C., Colwell, B., Abulhosn, K., Noonan, C., et al. (2002). Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. AIDS Patient Care and STDs, 16, 157-172.
21.
McCance-Katz, E. F., Gourevitch, M. N., Arnsten, J., Sarlo, J., Rainey, P., & Jatlow, P. (2002). Modified directly observed therapy (MDOT) for injection drug users with HIV disease. American Journal on Addictions, 11, 271-278.
22.
Mehta, S., Moore, R. D., & Graham, N. M. (1997). Potential factors affecting adherence with HIV therapy. AIDS, 11, 1665-1670.
23.
Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change (2nd ed.). New York: Guilford.
24.
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. American College of Physicians: American Society of Internal Medicine, 133, 21-30.
25.
Petry, N. (2000). A comprehensive guide to the application of contingency management procedures in clinical settings. Drug and Alcohol Dependence, 58, 9-26.
26.
Petry, N. M., Alessi, S. M., Marx, J., Austin, M., & Tardif, M. (2005). Vouchers versus prizes: Contingency management treatment of substance abusers in community settings. Journal of Consulting and Clinical Psychology, 6, 1005-1014.
27.
Petry, N. M., & Bohn, M. J. (2003, August). Fishbowls and candy bars: Using low-cost incentives to increase treatment retention. Science and Practice Perspectives, 2(1), 55-61.
28.
Petry, N. M., Martin, B., Cooney, J. L., & Kranzler, H. R. (2000). Give them prizes and they will come: Contingency management for the treatment of alcohol dependence. Journal of Consulting and Clinical Psychology, 68, 250-257.
29.
Preston, K. L., Silverman, K., Umbricht, A., DeJesus, A., Montoya, I., & Schuster, C. (1999). Improvement in naltrexone compliance with contingency management. Drug and Alcohol Dependence, 54, 127-135.
30.
Rigsby, M. O., Rosen, M. I., Beauvais, J., Cramer, J. A., Rainey, P. M., O’Malley, S. S., et al. (2000). Cue-dose training with monetary reinforcement: Pilot study of an antiretroviral adherence intervention. Journal of General Internal Medicine, 15, 891-893.
31.
Roll, J. M., Higgins, S. T., & Badger, G. J. (1996). An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. Journal of Applied Behavior Analysis, 29, 495-505.
32.
Silverman, K., Higgins, S. T., Brooner, R. K., Montoya, I. D., Cone, E. J., Schuster, C. R., et al. (1996). Sustained cocaine abstinence in methadone maintenance clients through voucher-based reinforcement therapy. Archives of General Psychiatry, 53, 409-415.
33.
Silverman, K., Wong, C. J., Higgins, S. T., Brooner, R. K., Montoya, I. D., Contoreggi, C., et al. (1996). Increasing opiate abstinence through voucher-based reinforcement therapy. Drug and Alcohol Dependence, 41, 157-165.
34.
Sorensen, J. L., Haug, N. A., Delucchi, K., Gruber, V., Kletter, E., Batki, S. L., et al. (2006). Voucher reinforcement improves medication adherence in HIV-positive methadone patients: A randomized clinical trial. Manuscript submitted for publication.
35.
Sorensen, J. L., Haug, N. A., Delucchi, K., Gruber, V., Tulsky, J. P., Hall, S. M., et al. (2004, June). Voucher reinforcement trial to improve methadone treatment for injection drug users with HIV Infection. Paper presented at the College on Problems of Drug Dependence 66th annual scientific meeting, San Juan, Puerto Rico.
36.
Sorensen, J. L., Mascovich, A., Wall, T. L., DePhilippis, D., Batki, S. L., & Chesney, M. (1998). Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care, 10, 292-312.
37.
Umbricht-Schneiter, A., Ginn, D. H., Pabst, K. M., & Bigelow, G. E. (1994). Providing medical care to methadone clinic patients: Referral vs. onsite care. American Journal of Public Health, 84, 207-210.
38.
Wendel, C. S., Mohler, M. J., Kroesen, K., Ampel, N. M., Gifford, A. L., & Coons, S. J. (2001). Barriers to use of electronic adherence monitoring in an HIV clinic. Annals of Pharmacotherapy, 35, 1010-1015.
39.
West Portal Software Corporation. (2003). CASIC builder. San Francisco: Author. Available at www.hivadhere.com/products/CASIBuilder.aspx
